A nationally developed SMBG guideline has been developed in Iran, offering frequency and timing recommendations based on diabetes type, treatment regimen, and level of glycemic control, aligned with international guidelines. Given the crucial role of SMBG in diabetes care, this national consensus aims to be implemented in clinical practice and policy-making.
Jahed et al. (Wed,) studied this question.